300238 冠昊生物
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资0-100.00%1924,49016,92517,406
投资性房地产8,013-1.37%8,1248,5699,0140
固定资产306,841-0.95%309,796319,542161,958182,734
在建工程21,71020.44%18,0262,54273,9912,802
无形资产70,599-1.69%71,81472,70278,66087,492
商誉0--0000
其他非流动资产72,218-1.03%72,97380,76570,76880,950
479,380-0.32%480,924488,610411,317371,383

流动资产
货币资金144,224-10.20%160,605106,780105,136126,280
应收账款61,06216.41%52,45359,54661,14371,976
存货71,003-8.63%77,70878,45971,60161,677
其他流动资产31,554-9.44%34,84321,00529,39838,956
307,843-5.46%325,608265,790267,278298,889

流动负债
短期借款14,990-0.07%15,00020,01524,51949,048
应付票据0--0000
应付帐款13,978-30.56%20,12935,65029,3232,164
其他流动负债124,632-18.76%153,411122,327118,874137,777
153,600-18.53%188,541177,991172,716188,989
流动资产净值154,24312.53%137,06887,79994,562109,900
资产总额减流动负债633,6232.53%617,992576,409505,879481,284

非流动负债
长期借款113,2449.00%103,89376,00012,0150
应付债券0--0000
其他非流动负债25,472-3.08%26,28232,81737,60350,340
138,7166.56%130,175108,81749,61850,340

总权益
    实收股本265,1560.00%265,156265,156265,156265,156
    储备项目314,9623.30%304,912277,202255,438220,188
股东权益580,1181.76%570,068542,358520,594485,344
非控股权益(85,210)3.60%(82,251)(74,766)(64,334)(54,400)